The Evolution Of US FDA Advisory Committee Votes On COVID-19 Vaccines

 
• By Derrick Gingery

From surprisingly contentious to surprisingly unanimous, VRBPAC's favorable votes have grown from 17 to 21 over the course of three meetings on coronavirus vaccines.

Closeup of multiethnic men and women raising hands against white background. Shutterstock-144918361
The VRBPAC voted 21-0 to recommend an emergency use authorization for the J&J COVID-19 vaccine.

More from Vaccines

More from Pink Sheet